The real cancer crisis isn’t just biological — it’s deeply human. While science races ahead with groundbreaking treatments, millions of people living with cancer continue to feel unseen, unheard, and unsupported. A new report from King’s College London and international collaborators is sounding the alarm: progress in cancer research isn’t being matched by progress in human care. And this is where the debate begins — have we built a system that prioritizes machines and molecules over meaning and compassion?
Launched at the AORTIC conference in Tunis, The Lancet Oncology Commission: The Human Crisis in Cancer is the product of two years of work by experts from 11 nations, blending insights from oncology, mental health, economics, and social science. Co-led by the Institute of Cancer Policy at King’s and the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) in Canada, the Commission exposes a sobering truth: despite astonishing advances in medical science — from precision therapies and surgical robotics to AI-driven diagnostics — the global cancer care system often fails to meet the most basic emotional and psychological needs of patients and their families.
The Commission draws not only on data but also on lived experiences of people navigating cancer treatment around the world. It reveals a widening divide between what science can achieve and what people actually experience. In many low-resource, conflict-affected, or marginalized communities, care remains fragmented, communication is poor, and palliative and mental health support are often introduced too late — if at all. The report directly challenges the comfortable narrative that global cancer care is in a constant state of improvement. Instead, it exposes how entire systems, designed around efficiency and profit, frequently neglect the very individuals they’re supposed to protect.
Here’s the controversial part: this isn’t about bad doctors or negligent nurses. The Commission makes it clear that these systemic failures stem from how the global health system has been designed — one that rewards technology, throughput, and marketable innovation, while undervaluing empathy, connection, and human presence. Care models have become increasingly transactional, leaving patients feeling isolated within a system that measures success in survival rates but not in dignity or quality of life.
The consequences hit hardest among those already living on the margins — people facing poverty, stigma, discrimination, or conflict. The report calls for a radical shift: to rebuild cancer care around the patient, not the profit. It argues that some of the most effective ways to reduce suffering, like patient navigation, early palliative involvement, psychosocial support, and systematic distress screening, are already proven, affordable, and scalable. Yet these approaches remain underused simply because they don’t generate revenue.
The Commission insists that compassion, dignity, and presence must become the hallmarks of quality cancer care. It urges global systems to integrate mental health and palliative care from the very beginning of the treatment journey — not as afterthoughts. It also calls for major reforms in training, research funding, and reimbursement systems to align them with what patients actually value most: humanity, not just innovation.
According to Professor Richard Sullivan, Director of the Institute of Cancer Policy at King’s and Co-Director of the Centre for Conflict & Health Security, “we’re witnessing a crisis of meaning and connection in cancer care.” But he adds that this decline is not inevitable. With deliberate restructuring and a renewed focus on person-centered care, the world can build systems that truly serve patients rather than market interests.
Ultimately, the Commission’s resounding message is this: cancer care has lost sight of the relationships that define healing. Without bringing the human back into medicine, no amount of scientific progress can fix the crisis. But here’s the question worth debating — can global cancer systems truly change course in a world where profit still dictates policy? What do you think — is the future of cancer care destined to be human-centered, or will technology continue to lead the way?
